Flash Buy: The Big Players Finally Discover Our Stock
You always know you’ve got a winner small-cap biotech when the larger investment firms finally catch on. That has been happening a lot in the last few weeks with a one-drug company with an intervention for prostate cancer (and possibly breast cancer) that I recommended in November at $62 a share.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.